Jacquelyn is currently Director, Regulatory Policy and Intelligence at BMS. In this role she is responsible for evaluating trends in the regulatory environment and working with stakeholders to advocate for policies supporting development of innovative medicines. Her current areas of focus are on regulatory policies impacting ATMPs, paediatric drug development and supporting regulatory project teams in the Hematology & Cell Therapy therapeutic areas. She has been managing projects, leading initiatives, and designing processes to understand and assess the impact of regulatory policy changes on strategy, operations, and compliance in the pharmaceutical industry for 15+ years. She holds a degree in Cell Biology & Biochemistry from Bucknell University and a MSc from the London School of Economics and Political Science.